title: Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.
abstract: Human plasma platelet-activating factor (PAF) acetylhydrolase functions by reducing PAF levels as a general anti-inflammatory scavenger and is linked to anaphylactic shock, asthma, and allergic reactions. The enzyme has also been implicated in hydrolytic activities of other pro-inflammatory agents, such as sn-2 oxidatively fragmented phospholipids. This plasma enzyme is tightly bound to low and high density lipoprotein particles and is also referred to as lipoprotein-associated phospholipase A2. The crystal structure of this enzyme has been solved from x-ray diffraction data collected to a resolution of 1.5 angstroms. It has a classic lipase alpha/beta-hydrolase fold, and it contains a catalytic triad of Ser273, His351, and Asp296. Two clusters of hydrophobic residues define the probable interface-binding region, and a prediction is given of how the enzyme is bound to lipoproteins. Additionally, an acidic patch of 10 carboxylate residues and a neighboring basic patch of three residues are suggested to play a role in high density lipoprotein/low density lipoprotein partitioning. A crystal structure is also presented of PAF acetylhydrolase reacted with the organophosphate compound paraoxon via its active site Ser273. The resulting diethyl phosphoryl complex was used to model the tetrahedral intermediate of the substrate PAF to the active site. The model of interface binding begins to explain the known specificity of lipoprotein-bound substrates and how the active site can be both close to the hydrophobic-hydrophilic interface and at the same time be accessible to the aqueous phase.
authors.affiliation: Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, USA.
authors.forename: Uttamkumar
authors.initials: U
authors.lastname: Samanta
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Bahnson
mesh_terms: D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D055162:Biocatalysis; D018360:Crystallography, X-Ray; D006801:Humans; D008074:Lipoproteins / Q000737:chemistry* / Q000378:metabolism*; D008958:Models, Molecular; D010972:Platelet Activating Factor / Q000378:metabolism*; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D017434:Protein Structure, Tertiary; D021122:Protein Subunits / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013379:Substrate Specificity
chemical_list: D008074:Lipoproteins; D010972:Platelet Activating Factor; D021122:Protein Subunits; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase
references.citation: Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
references.pmid: 15299374
references.citation: Structure. 1998 Apr 15;6(4):511-9
references.pmid: 9562561
references.citation: Methods Enzymol. 1997;277:319-43
references.pmid: 18488315
references.citation: Science. 1996 Aug 2;273(5275):595-603
references.pmid: 8662544
references.citation: Cell Mol Life Sci. 1998 May;54(5):446-55
references.pmid: 9645224
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: Mol Cell Biochem. 2007 Jan;295(1-2):113-20
references.pmid: 16896535
references.citation: Biochemistry. 2001 Apr 17;40(15):4539-49
references.pmid: 11294621
references.citation: Nat Struct Biol. 1999 May;6(5):458-63
references.pmid: 10331874
references.citation: Neuron. 2004 Dec 2;44(5):809-21
references.pmid: 15572112
references.citation: Nature. 1995 Apr 6;374(6522):549-53
references.pmid: 7700381
references.citation: Nat Methods. 2008 Feb;5(2):119
references.pmid: 18235431
references.citation: Protein Sci. 2006 Jun;15(6):1318-33
references.pmid: 16731967
references.citation: J Biol Chem. 1999 Mar 12;274(11):7018-24
references.pmid: 10066756
references.citation: J Am Coll Cardiol. 2008 Apr 29;51(17):1632-41
references.pmid: 18436114
references.citation: J Clin Invest. 1999 Apr;103(7):989-97
references.pmid: 10194471
references.citation: N Engl J Med. 2000 Oct 19;343(16):1148-55
references.pmid: 11036120
references.citation: Atherosclerosis. 2003 Jun;168(2):283-8
references.pmid: 12801611
references.citation: Protein Pept Lett. 2009;16(1):97-100
references.pmid: 19149681
references.citation: Bioinformatics. 2006 Mar 1;22(5):623-5
references.pmid: 16397007
references.citation: Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:83-94
references.pmid: 12432911
references.citation: Biochim Biophys Acta. 2006 Nov;1761(11):1246-59
references.pmid: 16973413
references.citation: Hum Mol Genet. 2004 Jul 1;13(13):1341-51
references.pmid: 15115767
references.citation: Protein Eng. 1992 Apr;5(3):197-211
references.pmid: 1409539
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: Biochemistry. 1999 Sep 28;38(39):12935-42
references.pmid: 10504265
references.citation: Biochim Biophys Acta. 2000 Oct 31;1488(1-2):102-23
references.pmid: 11080681
references.citation: Stroke. 2008 May;39(5):1448-55
references.pmid: 18356547
references.citation: J Biol Chem. 2008 Mar 7;283(10):6428-37
references.pmid: 18165686
references.citation: Biochim Biophys Acta. 2006 Nov;1761(11):1359-72
references.pmid: 17049457
references.citation: Nature. 1997 Jan 2;385(6611):89-93
references.pmid: 8985254
references.citation: Curr Opin Lipidol. 2005 Aug;16(4):442-6
references.pmid: 15990594
references.citation: FASEB J. 2007 Apr;21(4):1164-76
references.pmid: 17210780
references.citation: J Biol Chem. 1990 Oct 15;265(29):17381-4
references.pmid: 2170377
references.citation: J Biol Chem. 1991 Jun 15;266(17):11095-103
references.pmid: 2040620
references.citation: J Mol Biol. 2007 Sep 21;372(3):774-97
references.pmid: 17681537
references.citation: Curr Opin Pharmacol. 2006 Apr;6(2):154-61
references.pmid: 16495153
references.citation: BMC Struct Biol. 2007 Jun 29;7:44
references.pmid: 17603894
references.citation: Eur Heart J. 2005 Jan;26(2):107-9
references.pmid: 15618064
references.citation: Methods Enzymol. 2003;374:22-37
references.pmid: 14696367
references.citation: Protein Eng. 2002 Aug;15(8):659-67
references.pmid: 12364580
references.citation: Annu Rev Biochem. 2000;69:419-45
references.pmid: 10966465
references.citation: Biochim Biophys Acta. 2000 Oct 31;1488(1-2):20-7
references.pmid: 11080673
references.citation: Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70
references.pmid: 12643913
references.citation: J Biol Chem. 1995 Oct 27;270(43):25481-7
references.pmid: 7592717
references.citation: Am J Hum Genet. 2000 May;66(5):1522-30
references.pmid: 10733466
references.citation: J Biol Chem. 2008 Jun 20;283(25):17099-106
references.pmid: 18434304